SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (266)9/13/2002 12:45:30 AM
From: scaram(o)uche  Respond to of 631
 
I'm certain that they will. I was just ticked at the spin.

But.... FDA is obligated to respond in six months to a very high percentage of class II resubmissions, not all of them. I forget the exact figure..... probably 90% or better.

But you're correct, as far as practice will unfold.